Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2025-12-24 @ 2:59 PM
NCT ID:
NCT02952859
Eligibility Criteria:
Inclusion Criteria:
* Patients with histology proven or highly suspected potentially resectable or borderline resectable pancreatic cancer will be included.
* Age ≥ 18 years
* Able to undergo general anesthesia (ASA ≤ 3)
* Performance status ECOG \<=2 (Eastern Cooperative Oncology Group)
* Life expectancy of at least 6 months
* Resectable or borderline resectable proven pancreatic adenocarcinoma of the pancreas
Exclusion Criteria:
* Cardiac conduction abnormalities (AV conduction abnormalities)
* History of epilepsy
* Recent history of myocardial infarction (2 months)
* Evidence of distant metastasis (e.g. liver, lung, peritoneum)
* Informed consent cannot be given by the patient
* Known hypersensitivity to the IRE electrodes (stainless steel 304L)
* Women of childbearing potential who are pregnant, breast feeding, or not taking an adequate method of contraception at the time of procedure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02952859
Study Brief:
Protocol Section:
NCT02952859